Research To Practice | Oncology Videos Pancreatic Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Pancreatic Cancer with Dr Michael Pishvaian
Oct 13, 2023
57:42
Featuring an interview with Dr Michael Pishvaian, including the following topics:
- Importance of next-generation sequencing as part of the diagnostic workup for metastatic pancreatic cancer (0:00)
- Optimal treatment selection for patients with germline BRCA mutation-positive pancreatic cancer (3:32)
- NAPOLI-3 Phase III trial of liposomal irinotecan with 5-fluorouracil/leucovorin and oxaliplatin (NALIRIFOX) versus gemcitabine/nab paclitaxel for treatment-naïve metastatic pancreatic ductal carcinoma (5:48)
- Perspectives on the comparative efficacy and tolerability of 2-drug and 3-drug treatment regimens in the metastatic setting; perioperative versus adjuvant therapy in locally advanced disease (9:22)
- Novel treatment approaches for pancreatic cancer — zolbetuximab, tumor treating fields and intra-arterial gemcitabine (14:35)
- Role of radiation therapy in the management of pancreatic cancer; early-phase data with novel antibody-drug conjugates (22:14)
- Selection of second-line therapy for metastatic pancreatic cancer (26:15)
- PARP inhibition for the treatment of pancreatic cancer (32:27)
- Investigational approaches for the treatment of KRAS mutation-positive pancreatic cancer (48:50)
- Vaccine-based treatment approaches under development for pancreatic cancer; palliative care strategies (52:04)